The clinical effect of botulinum toxin on pigmentation

被引:2
|
作者
Erdil, Duygu [1 ]
Manav, Vildan [1 ]
Turk, Cemre B. [1 ]
Polat, Asude Kara [1 ]
Aksu, Ayse E. Koku [1 ]
机构
[1] Univ Hlth Sci Turkey, Istanbul Training & Res Hosp, Clin Dermatol, Istanbul, Turkey
关键词
SKIN; MELANOCYTES; ERYTHEMA; BIOLOGY; MELANIN;
D O I
10.1111/ijd.16522
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BackgroundBotulinum toxin injection is a common cosmetic procedure often used to treat dynamic wrinkles, but it has also been observed to have a lightening effect on the skin. It is thought that this lightening effect develops due to muscle innervation blockage; however, the change in the amount of melanin levels has not been quantified. MethodThirty-one patients who presented to the dermatology clinic of a tertiary hospital for botulinum toxin injection for wrinkle treatment were included in the study. A standard dose of botulinum toxin was injected to each patient's forehead, glabellar, and crow's feet region, and then the melanin index (MI) was measured with the Mexameter (R) MX 18 (Courage + Khazaka Electronic, Koln). ResultsAfter botulinum toxin treatment, a statistically significant decrease was found in the forehead and upper face MI. The upper face total baseline MI was significantly lower in the Glogau 1 group than in the Glogau 2 group (P = 0.033). The forehead 15th day MI was significantly lower in the Glogau 1 group than in the Glogau 2, 3, and 4 groups (P = 0.030). DiscussionBotulinum toxin application to healthy skin for wrinkle treatment can cause facial skin lightening by reducing MI. It was also remarkable that this decrease was more pronounced in the forehead, which is a region that is particularly vulnerable to sun exposure, compared to other regions. Younger people, who are included in the Glogau type 1 group, may benefit more from this lightening effect.
引用
收藏
页码:250 / 256
页数:7
相关论文
共 50 条
  • [41] Botulinum Toxin and the Treatment of Headache: A Clinical Review
    Finkel, Alan G.
    HEADACHE, 2011, 51 (10): : 1565 - 1572
  • [42] Clinical trials of botulinum toxin in the treatment of spasticity
    Simpson, DM
    MUSCLE & NERVE, 1997, : S169 - S175
  • [43] Botulinum toxin and the treatment of headache: A clinical review
    Finkel, Alan G.
    TOXICON, 2015, 107 : 114 - 119
  • [44] Use of Botulinum Toxin in Orofacial Clinical Practice
    Serrera-Figallo, Maria-Angeles
    Ruiz-de-Leon-Hernandez, Gonzalo
    Torres-Lagares, Daniel
    Castro-Araya, Alejandra
    Torres-Ferrerosa, Omar
    Hernandez-Pacheco, Esther
    Gutierrez-Perez, Jose-Luis
    TOXINS, 2020, 12 (02)
  • [45] Clinical comparability of marketed formulations of botulinum toxin
    Sampaio, C
    Costa, J
    Ferreira, JJ
    MOVEMENT DISORDERS, 2004, 19 : S129 - S136
  • [46] Clinical Application of Botulinum Toxin for Hemifacial Spasm
    Park, Chang-Kyu
    Lim, Seung-Hoon
    Park, Kwan
    LIFE-BASEL, 2023, 13 (08):
  • [47] Clinical failure of botulinum toxin A in movement disorders
    Savica, Rodolfo
    Grossardt, Brandon R.
    Bower, James H.
    Klassen, Bryan T.
    Matsumoto, Joseph Y.
    PARKINSONISM & RELATED DISORDERS, 2012, 18 (01) : 73 - 75
  • [48] History of the clinical use of botulinum toxin A and B
    Carruthers, A
    CLINICS IN DERMATOLOGY, 2003, 21 (06) : 469 - 472
  • [49] Botulinum toxin in the clinical management of cervical dystonia
    Comella, CL
    NEUROLOGY, 2000, 55 (12) : S1 - S1
  • [50] CLINICAL CORRELATES OF RESPONSE TO BOTULINUM TOXIN INJECTIONS
    JANKOVIC, J
    SCHWARTZ, KS
    ARCHIVES OF NEUROLOGY, 1991, 48 (12) : 1253 - 1256